Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 2 subfamily G member 1, pseudogene (CYP2G1P), is a non-functional pseudogene in humans and part of the larger cytochrome P450 family, members of which encode monooxygenase enzymes involved in metabolism of drugs, steroids, and other substrates. CYP2G1P does not encode a functional enzyme, but some studies indicate that pseudogenes like CYP2G1P can be differentially expressed in disease tissues, such as being downregulated in nasopharyngeal carcinoma compared to adjacent normal tissue, and may play a role in tumorigenesis via regulation of related pathways or gene expression at the RNA level. No drugs are known to target this pseudogene, and it is not considered a therapeutic target
None (not a therapeutic target due to pseudogene status)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 2 subfamily G member 1, pseudogene (CYP2G1P).